Invention Grant
- Patent Title: Cyclopropanecarboxylic acid GPR120 modulators
-
Application No.: US15509214Application Date: 2015-09-08
-
Publication No.: US09938222B2Publication Date: 2018-04-10
- Inventor: Yan Shi , Peter T. W. Cheng , Ying Wang , Sutjano Jusuf , Shiwei Tao , Hao Zhang , Shung C. Wu , Jeffrey A. Robl
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Jing G. Sun
- International Application: PCT/US2015/048781 WO 20150908
- International Announcement: WO2016/040222 WO 20160317
- Main IPC: C07C62/34
- IPC: C07C62/34 ; C07C59/64 ; C07D307/79 ; C07D277/30 ; C07D213/55 ; C07D231/12 ; C07D213/65
Abstract:
The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR120 G protein-coupled receptor modulators which may be used as medicaments.
Public/Granted literature
- US20170253554A1 CYCLOPROPANECARBOXYLIC ACID GPR120 MODULATORS Public/Granted day:2017-09-07
Information query
